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Abstract
Background: CD8
+ suppressor T cells exert antigen-specific suppression of the expression of hypersensitivity by activated T
cells. Therefore, CD8
+ suppressor T cells serve a major regulatory role for the control of active immunity. Accordingly, the
number and/or activity of CD8
+ suppressor T cells should be influenced by an immune response to the antigen. To test this
hypothesis we used an adoptive transfer assay that measures the suppression of the expression of delayed-type
hypersensitivity (DTH) by CD8
+ suppressor T cells to quantify the antigen-specific suppression of DTH by these suppressor T
cells.
Methods: Suppressor T cells were induced in the spleens of mice by the injection of antigen into the anterior chamber of an
eye. Following this injection, the mice were immunized by the same antigen injected into the anterior chamber. Spleen cells
recovered from these mice (AC-SPL cells) were titrated in an adoptive transfer assay to determine the number of AC-SPL
cells required to effect a 50% reduction of antigen-induced swelling (Sw50) in the footpad of immunized mice challenged
by antigen.
Results: Suppression of the expression of DTH is proportional to the number of AC-SPL cells injected into the site
challenged by antigen. The number of AC-SPL cells required for a 50% reduction in DTH-induced swelling is reduced by
injecting a cell population enriched for CD8
+ AC-SPL cells. Immunizing the mice receiving intracameral antigen to the same
antigen decreases the RSw50 of AC-SPL cells required to inhibit the expression of DTH.
Conclusions: The results provide the first quantitative demonstration that the numbers of antigen-specific splenic CD8
+
suppressor T cells are specifically amplified by antigen during an immune response.
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Introduction
CD8
+ suppressor T cells execute a Qa-1-restricted, antigen-
specific suppression of activated T cells [1–12]. Unlike CD4
+,
FoxP3
+ regulatory T cells (T reg), CD8
+ suppressor T cells inhibit
activated T effector cells whose actions may cause autoimmune
disease [1–4]. Accordingly, understanding the activation and
activity of these suppressor T cells could provide insight into the
mechanisms of suppression and perhaps the development of
therapeutic modalities that use these cells to modulate inflamma-
tory diseases. Surprisingly, although known for more than 25 years
[1,12], the activation, indeed the existence of CD8
+ suppressor T
cells is not well understood.
The activity of CD8
+ suppressor T cells is evident after
immunization [3,5], consistent with the antigen specificity of the
suppression mediated by these cells. Accordingly, immunization
should induce a specific increase in CD8
+ suppressor T cells
responding to the antigen and/or a variable region epitope of the
receptor of T cells specific for the antigen [1,2,8]. This increase in
suppressor T cells could be due to the amplification of T cell clones
that are the precursors of CD8
+ suppressor T cells and/or to
effector T cells that are ‘‘converted’’ to a suppressive phenotype
[10,11]. Although CD8
+ suppressor T cells are phenotypically and
functionally distinct from CD4
+, FoxP3
+ regulatory T cells there is
presently no marker to identify (and therefore enumerate) these
cells. Accordingly, a quantitative functional assay of the activity of
suppressor T cells could provide a metric to estimate CD8
+
suppressor T cells and understand the nature of the activation and
function of these immunoregulatory T cells in vivo.
Although there are several procedures to induce suppressor T
cells in vivo [1], the injection of antigen into the anterior chamber
of an eye attracts circulating F4/80
+ monocytes to the anterior
chamber that traverse the anterior chamber and recirculate to the
thymus and spleen [13]. In the spleen, these monocytes interact
with CD4
+ T cells, B cells and recruited regulatory recent thymic
emigrants to induce antigen specific CD8
+ T suppressor T cells
that suppress the expression of DTH to the same antigen injected
into the anterior chamber [13–21]. In aggregate, Anterior
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appears to be the result of a moderate inflammatory response to
ocular injury. Quantifying the functional activity of splenic
suppressor T cells induced by the intracameral injection of antigen
could provide a metric to quantify ACAID) and provide
information to quantify this phenomenon as well as understand
the development of suppressor T cells.
We here investigated the immunologic basis of the in vivo
production of splenic antigen-specific suppressor T cells induced
by the intracameral injection of antigen using an in vivo assay of the
suppression of the expression of DTH by CD8
+ suppressor T cells.
The results show for the first time that immunization amplifies
quantitatively splenic CD8
+ suppressor T cells induced by the
intracameral injection of antigen. Moreover, the suppressive
activity of these cells is transient and only expressed for less than
three days at the site in immunized mice where the suppressor cells
were introduced.
Materials and Methods
Mice
Female or male BALB/c or C57Bl/6 mice, 8–10 weeks old,
were purchased from Charles River/NCI Laboratories (Wiliming-
ton,MA). The mice were maintained in the Center for Laboratory
Animal Care of the University of Connecticut Health Center. All
work with animals was approved previously by the University of
Connecticut Health Center Animal Care Committee (ACC-2004-
098, 2007-369). All animals were treated according to the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research.
Reagents and Immunization
2,4,6, Trinitrobenzene sulphonic acid (TNBS), bovine serum
albumin (BSA) and ovalbumin (OVA) were purchased from Sigma
Aldrich Chemical Co. (St. Louis, MO). Trinitrophenylated bovine
serum albumin (TNP-BSA) was prepared by conjugating TNBS to
BSA as described [9]. Picryl chloride (PCl), 2-chloro-1,3,5-
trinitorobenzene was purchased as 2-chloro-5-trypthtane from
Chemical Alta Ltd (Edmonton, Alberta, Canada). Unless specified
otherwise, mice were immunized by a single sc injection of 200 mg
TNP-BSA or OVA in 50 ml Freund’s Complete Adjuvant (CFA,
Sigma) into a flank. In general, the mice were challenged to induce
the expression of DTH sensitivity 7–10 days after the mice were
immunized.
Initiation of the expression of Delayed-Type
Hypersensitivity (DTH)
Contact sensitivity (CS) to TNP in TNP-BSA-sensitized or
naı ¨ve mice was induced by the epicutaneous application of 15 ml
1% PCl (the antigenic equivalent of TNP) in acetone:olive oil 4:1
to a footpad. The CS response was usually measured approxi-
mately 24 hr and 48 hr after the application of PCl by measuring
footpad thickness with an engineer’s digital micrometer (Mita-
toyo, Tokyo, Japan). Mice were anesthetized with ketamine/
xylazine (please see below) and the thickness of each footpad
measured. One footpad was then challenged with PCl and the
other with vehicle only. Twenty-four hr later the mice were
anesthetized again and the thickness of each footpad measured.
The thickness of each footpad before the application of PCl was
subtracted from that of the thickness of the footpad 24–48 hr
after the application of PCl. Swelling was computed as the
difference between the thickness of the challenged footpad minus
that of the unchallenged footpad.
Injection of antigen into the anterior chamber
(intracameral injection)
Mice were immunized with TNP-BSA 7 days after the injection
of antigen into the anterior chamber as described [9]. Mice were
anesthetized with ketamine (75 mg/kg)/xylazine (15 mg/kg) and
under a dissecting microscope a 30 g needle attached to a cannula
attached to a manually controlled Hamilton syringe (Stoelting Co,
Woodale, IL) was inserted into the anterior chamber. Approxi-
mately 4 ml phosphate-buffered saline (PBS pH 7.2) containing
4 mg TNP-BSA or 50 mg OVA was injected into the anterior
chamber (AC). The mice recovered approximately 30 min after
the injection and exhibited no distress, eating and drinking
normally.
Spleen cell preparation
Seven days after receiving an intracameral injection of TNP-
BSA or OVA, the mice were euthanized, spleens recovered from
the mice, diced and expressed through a 70 mm cell strainer
(Becton Dickinson, BD, Rockville,MD), into PBS. These spleen
cells (AC-SPL cells) were washed 2 times. To separate the AC-SPL
cells based on the expression of CD8, the cells were suspended in
PBS or BD
TM IMag separation buffer ). The spleen cells were
separated by immunomagnetic beads into CD8
+ and CD8
2
populations with a BD
TM CD8 T lymphocyte enrichment set
according to the manufacturer’s protocol. Enrichment was
assessed by immnofluorescent staining of the cells using BD
TM
fluorescein isothiocyanate (FITC)-anti-CD8 antibodies. Approxi-
mately 80–95% CD8
+ spleen cells were prepared after treatment
with the CD8 enrichment kit.
Adoptive transfer (Local Transfer of Suppression, LTS)
Splenic regulatory T cells: Regulatory-effector T cells were
assayed by the Local Transfer of Suppression assay (LTS [9]) for
CD8
+ regulatory T cells. All cells were suspended in PBS for
injection. Cells were quantified with a Beckman Coulter Counter.
Between 250 and 25000 spleen cells from AC-injected donors at
1610
8 /ml were injected subcutaneously (sc) into the footpads of
immunized mice immediately following epicutaneous challenge
with PCl. Swelling induced by PCl was measured 24–48 hr after
challenge.
Statistics
Statistical significance was calculated by one-way ANOVA. P-
values were determined by the Student-Neuman-Keuls test and p
values,0.05 were considered significant.
Results
Suppression of the expression of DTH in the LTS by
AC-SPL cells is proportional to the number of transferred
cells
AC-SPL cell populations contain CD8
+ suppressor T cells that
suppress the expression of DTH when transferred to a site in
immunized mice challenged with antigen to induce a DTH
reaction [9,21]. Presently, there is no marker to identify these
suppressor cells so that they can be quantified. We reasoned that
we could quantify the activity of CD8
+ suppressor T cells by
measuring the suppression of DTH using an assay that measures
solely CD8
+ suppressor T cell-mediated suppression of the
expression of DTH [9,21]. Therefore, suppressor cell donors
received an intracameral injection of TNP-BSA and were
immunized systemically with TNP-BSA to generate CD8
+
suppressor T cells. One week after these mice were immunized,
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prepared. We then titrated the activity of the suppressor cells to
suppress the expression of DTH in immunized mice. Two
hundred fifty-25, 000 total spleen cells recovered from the donors
that received an intracameral injection of antigen (AC-SPL cells )
were injected into the footpads of the TNP-BSA-immunized mice
immediately after the footpad was challenged epicutaneously with
PCl. Positive control immunized mice received epicutaneous PCl
but no AC-SPL cells and negative controls were naı ¨ve mice
challenged with epicutaneous PCl only. The thickness of the
footpads was measured before the challenge with antigen, +/2
AC-SPL cells and then 24 and 48 hr after challenge with PCl to
determine specific footpad swelling. Immunized mice that did not
receive AC-SPL cells had robust footpad swelling in response to
the antigenic challenge (greater than 2-fold the thickness obtained
with naı ¨ve mice). The PCl-induced swelling of the footpads of
TNP-BSA-immunized mice that received AC-SPL cells was
reduced significantly (Fig. 1 A–C). There was a linear relationship
between the reduction in the elicited footpad swelling and the
number of AC-SPL spleen cells injected into the footpad. (Fig. 1A).
Twenty-five thousand or 2800 naı ¨ve spleen cells did not suppress
the expression of DTH. Spleen cells recovered from control TNP-
BSA-immunized mice that did not receive an intracameral
injection of TNP-BSA or received an intracameral injection of
PBS only did not suppress swelling (Fig. 1C). Because of the
linearity in the reduction of PCl-induced swelling versus the
number of AC-SPL cells injected into the challenge site, we
derived a metric for the percent reduction in reduction in swelling
proportional to the number of AC-SPL spleen cells injected with
challenge antigen using a curve fit generated by the percent
reduction in DTH-induced swelling vs the number of regulatory
spleen cells injected into the site challenged by antigen. The
derivation of this metric is shown in Fig. 1B. Approximately 2,800
AC-SPL cells injected into the challenge site produced a 50%
reduction in swelling termed RSw50 since the 50% reduction in
swelling falls on the curve fit plot (Fig. 1B).
Because CD8
+ splenic suppressor T cells induced by the
intracameral injection of antigen are solely responsible for the
reduction in antigen-induced swelling in the LTS, we compared
quantitatively the suppressive activity of unseparated AC-SPL cells
to that of AC-SPL cells enriched for CD8
+cells. CD8
+ spleen cells
recovered from mice receiving intracameral TNP-BSA were
enriched to 85–95% from approximately 33–35% CD8
+cells.
(data not shown). Graded numbers of unseparated and CD8
+
spleen cells were injected into the footpads of TNP-BSA-
immunized mice immediately after the footpads were challenged
with epicutaneous PCl. The RSw50 obtained with unseparated
AC-SPL cells was approximately 2500 and 1260 for CD8
+ AC-
SPL cells (Fig. 2). Therefore, the number of AC-SPL cells enriched
for CD8
+ cells needed to cause a 50% reduction in antigen-
induced footpad swelling is approximately half that required using
unseparated spleen cells suggesting at least a 2-fold enrichment in
the CD8
+ AC-SPL suppressor cells. The injection of CD8
2spleen
cells recovered from mice receiving an intracameral injection of
TNP-BSA did not suppress footpad swelling (data not shown).
Immunization amplifies splenic suppressor T cells
induced by the intracameral injection of antigen
To determine whether immunizing amplifies splenic AC-SPL
suppressor cells, mice were immunized with TNP-BSA 7 days after
the mice received an intracameral injection of TNP-BSA. AC-SPL
cells recovered from these mice were compared for the suppression
of the expression of DTH to naı ¨ve mice that received an
intracameral injection of TNP-BSA only. The RSw50 obtained
from AC-SPL cells recovered from immunized mice, was
significantly less than that of AC-SPL cells recovered from mice
receiving an intracameral injection of TNP-BSA only (Fig. 3A)
indicating an increase in number and/or activity of suppressor
cells. To determine the antigen specificity of this increase, mice
receiving an intracameral injection of TNP-BSA were subsequent-
ly immunized with TNP-BSA or OVA. One week after
immunization, spleen cells were recovered and titrated in the
LTS assay for suppressor cells that regulated the DTH reaction to
PCl. Approximately 2500 spleen cells recovered from mice that
received an intracameral injection of TNP-BSA and were
immunized with TNP-BSA suppressed footpad swelling by 50%
in TNP-BSA- immunized mice. Comparatively, forty five hundred
spleen cells recovered from mice receiving an intracameral
injection of TNP-BSA and immunization with OVA suppressed
PCl-induced swelling in TNP-BSA-immunized mice by 50%
(Fig. 3B).
Quantitative increase of suppressor AC-SPL cells that
suppress specifically the expression of DTH depends on
antigen dose
The preceding results demonstrate that immunization ampli-
fies quantitatively splenic suppressor T cells active in the LTS.
Accordingly, the dose of antigen used in an immunization should
influence the propagation of these cells. To investigate this
hypothesis, BALB/c or C57BL/6 mice received an intracameral
injection of TNP-BSA and were then immunized with different
amounts of TNP-BSA. One week after immunization, spleen cells
were recovered from the mice. To ensure quantitative sensitivity
in the LTS, a limiting number (5000) of AC-SPL cells that falls on
the linear titration curve (fig. 1) were injected into the footpads of
syngeneic TNP-BSA-immunized mice immediately after the
footpad was challenged with epicutaneous PCl to elicit the
expression of DTH. Figure 4 compares the dose of TNP-BSA
required to stimulate DTH in BALB/c or C57BL/6 mice (Fig. 4
A,C) and the dose of immunizing TNP-BSA optimal to expand
splenic suppressor T cells after the intracameral injection of TNP-
BSA (Fig. 4 B,D). Two hundred mg of TNP-BSA was optimal to
induce DTH to TNP in both C57BL/6 and BALB/c mice
However, 100 or 400 mg TNP-BSA were less effective at inducing
DTH in BALB/c mice. Suppressor spleen cells recovered from
C57BL/6 donors immunized with 100 mg TNP-BSA were most
effective in suppressing the expression of DTH in the LTS
(Fig. 4D). Suppressor spleen cells recovered from C57BL/6 mice
immunized with 400 mg TNP-BSA were not suppressive.
However, the 400 mg dose was optimal to expand suppressor
spleen cells in BALB/c mice that received an intracameral
injection of TNP-BSA. Spleen cells recovered from BALB/c mice
immunized with 400 mg TNP-BSA but did not receive an
intracameral injection of TNP-BSA did not suppress PCl-induced
swelling (data not shown).
The suppression of the expression of DTH by CD8
+
regulatory spleen cells is transient
The preceding data demonstrates that the number of suppressor
cells needed to suppress the local expression of DTH in
immunized mice is specifically amplified by immunization with
the same antigen used to induce these cells. To determine
durability and timing of the suppressive ability at the site where
suppressor T cells were transferred, spleen cells recovered from
donor mice that received an intracameral injection of TNP-BSA
and immunization with TNP-BSA were injected into the footpads
of mice immunized with TNP-BSA. The mice were challenged
Immune Amplification of CD8
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P.I.) or 5 days (13 days P.I.) after the AC-SPL spleen cells were
injected into the footpad. Footpad swelling in response to
epicutaneous PCl was suppressed by 70% in mice challenged
immediately after the injection of spleen cells. However, swelling
was reduced only 30% in footpads challenged 3 days after the
injection of the AC-SPL cells and was not suppressed in footpads
challenged five days after the injection of the AC-SPL cells
(Fig. 5A). However, footpad swelling of immunized mice
challenged 11 or 13 days after immunization was suppressed by
the injection of AC-SPL cells concomitant with epicutaneous
challenge with PCl. We conclude that the lack of suppression of
swelling by suppressor spleen cells ‘‘parked’’at the challenge site
for 3 days or 5 days was not due to a resistance to suppression in
immune effector T cells 11 or 13 days after immunization.
(Fig. 5B).
Discussion
Cell-mediated regulation of an immune response is a complex
system that includes CD4
+, FoxP3
+regulatory T cells (Treg),
CD4
+, FoxP3
= T cells, NKT cells and CD8
+ T cells [1]. CD4
+,
FoxP3
+ T cells are not obligatory for ACAID [22]. However,]
CD4
+, FoxP3
= T cells and NKT cells both participate in the
induction of splenic CD8
+ suppressor T cells after the intracameral
injection of antigen [17,20]. Immunoregulatory thymic NKT cells
induced by an intracameral injection of antigen also emigrate from
the thymus to the spleen. In the spleen, CD4
+ T cells, peripheral
NKT cells, recent NKT thymic immigrants, B cells, and the F4/
80
+ cells influenced by transit through the anterior chamber
interact in the activation of CD8
+ regulatory T cells that effect the
suppression of effector Th1 cells [13–15,20–22]. Antigen is
required for the induction of CD8
+ suppressor T cells by
Figure 1. The suppression of the expression of DTH in the LTS by intracamerally-induced AC-SPL spleen cells is proportional to the
number of transferred AC-SPL cells. (A) Reduction in antigen-induced swelling by AC-SPL cells is proportional to the number of AC-SPL cells
transferred to the antigen challenge site. Spleen cells were recovered from donors that received an intracameral injection of TNP-BSA and were
immunized to TNP-BSA. Unfractionated AC-SPL cells were quantified with a Coulter counter and the number of cells shown injected id into the
footpads of TNP-BSA-immunized recipients immediately after the footpads were challenged with epicutaneous PCl. Open circles show naı ¨ve spleen
cells. Swelling was measured 24 hr after challenge. The data is pooled from 3–4 separate experiments and is the mean swelling +/2 SE of 8–12 mice/
group. IMM: mean swelling of immunized mice that received no AC-SPL cells. NAI ¨VE: mean swelling of challenged, non-immunized mice. The straight
line was generated by curve fit software. (B) The metric (RSw50) quantifies the suppression of DTH-induced swelling by AC-SPL cells. Suppression of
DTH-induced swelling by AC-SPL cells was computed as the specific swelling (mm) of the challenged footpad receiving AC-SPL cells/ specific swelling
of the challenged footpad that did not receive AC-SPL cells X 100. The straight line was generated by curve fit software. The data represents the
pooled mean suppression of swelling +/2 the standard error of the mean of five separate experiments, 15 mice/group. The number of AC-SPL cells
providing 50% suppression of DTH swelling (RSw50) is shown and was computed based on the curve fit. (C) Only AC-SPL cells recovered from mice
receiving an intracameral injection of TNP-BSA suppress TNP-induced swelling in TNP-immunized mice. The footpads of mice immunized with TNP-
BSA (IMM) or naı ¨ve mice received 25,000 spleen cells recovered from TNP-BSA-immunized mice (IMM-SPL) TNP-BSA-immunized that received
intracameral TNP-BSA (AC-TNP-BSA-SPL) or PBS only (AC-PBS-SPL) concomitant with epicutanteous PCl. Swelling was measured before and 24 hr
after challenge. Data is the mean swelling in three experiments, 3–4 mice/group/experiment (total of 9–12 mice/group). * P,.01.
doi:10.1371/journal.pone.0022496.g001
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+ regulatory spleen cells. The footpads of mice
immunized with TNP-BSA and CFA 9 days previously received id CD8
+ cells or unseparated AC-SPL cells prepared as in Fig. 1 immediately after the
footpad was challenged with epicutaneous PCl. Swelling was measured 24 hr later. The data is pooled from two separate experiments with six mice /
group. NAI ¨VE: non-immunized mice, IMM: immunized mice that did not receive regulatory spleen cells, CD8
+: immunized mice that received CD8
+
regulatory spleen cells. p,0.01. Straight lines were generated by curve fit software.
doi:10.1371/journal.pone.0022496.g002
Figure 3. Immunization reduces the RSw50 of AC-SPL cells. (A) BALB/c mice received an injection of TNP-BSA into the anterior chamber.
Seven days after receiving an intracameral injection of TNP-BSA, some mice were immunized with TNP-BSA/CFA. Spleen cells were recovered from
the immunized, AC-injected mice (AC-IMM) and mice that received an injection of antigen into the AC only (AC-ONLY) one week after the
immunization of AC-injected mice or one week after intracameral injection only. Twenty-five thousand AC-SPL cells were injected into the footpads of
TNP-BSA-immunized mice immediately after the footpads were challenged with epicutaneous PCl. (B) Immunization-induced increase in suppression
is antigen-specific. Seven days after mice received an intracameral injection of TNP-BSA, the mice were immunized with TNP (AC-TNP), TNP-IMM or
OVA (AC-TNP-OVA-IMM). Seven days after immunization, spleens were recovered from the mice and recovered spleen cells injected into the footpad
of TNP-BSA-immunized mice immediately after the footpad was challenge with epicutaneous PCl. Swelling was measured 24 hr later. The data
represents the mean RsW50 +/2 the standard error of the mean for three experiments, 9 mice/group. *p,0.02.
doi:10.1371/journal.pone.0022496.g003
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naı ¨ve mice or mice receiving an intracameral injection of PBS only
are not suppressive. In addition, AC-SPL cells recovered from
mice receiving an intracameral injection of an antigen different
from that used to immunize the mice do not suppress the
expression of DTH to another antigen [9,21,23].
The suppression of antigen-induced swelling (expression of
DTH) by AC-SPL cells is directly proportional to the number of
AC-SPL cells introduced to the site challenged by antigen. In fact,
the injection of AC-SPL cells intravenously at the time of challenge
does not suppress the expression of DTH [9,21]. Because of the
direct, quantitative relationship of the number of AC-SPL cells
required to suppress the expression of DTH, we derived a metric
to relate the number of AC-SPL cells required to effect a 50%
suppression of swelling (RSw50). WE reasoned that changes in the
RSw50 would reflect a change in the number and/or activity of
suppressor T cells in the AC-SPL cell population.
Since suppression of the expression of DTH in the LTS is due
solely to CD8
+ T cells, we titrated the suppressive activity of CD8
+
AC-SPL cells in the LTS vs unseparated AC-SPL cells. The lower
RSw50 of the CD8
+ cell-enriched AC-SPL cells (85–92%) as
compared to unseparated AC-SPL cells is consistent with the 33–
35% of CD8
+ cells in the latter population and substantiates the
use of the LTS to provide for a quantitative estimate of CD8
+
suppressor cell-mediated suppression. In the absence of a marker
for CD8
+ suppressor T cells, this assay does not provide for the
enumeration of CD8
+ suppressor T cells but does provide for a
quantitative estimate of the strength of suppression similar to that of
in vitro assays to measure cytotoxic T cells. However, the
suppression in the LTS is not dependent on cell-mediated
cytotoxicity [9].
The suppression of the expression of DTH in immunized mice
by CD8
+ AC-SPL suppressor T cells is dependent on TGF-b
produced by these cells [21,24] and is proportional to the number
of AC-SPL cells injected into the site challenged with antigen.
Because the suppression mediated by CD8
+ suppressor T cells is
not due to ‘‘bystander’’ suppression [9], suppression is likely
mediated by cell-cell contact consistent with the dose-response
relationships we observed between the reduction in DTH-induced
swelling and the number of CD8
+ suppressor spleen cells injected
into the site in immunized mice challenged with antigen.
Moreover, a single effector T cell can induce a DTH swelling
reaction [25]. Therefore, very few CD8
+ suppressor T cells would
be required to suppress the initiation of DTH-induced swelling. As
a result, these regulatory-effector cells suppress the Th1-mediated
recruitment of monocytic cells associated with swelling [9].
The increase in suppressor cell activity (reduction in RSw50)
induced by immunization with the same antigen as that injected
Figure 4. The expansion of AC-SPL suppressor cells that suppress the expression of DTH is strain and antigen dose -dependent.
Seven days after mice were immunized with TNP-BSA, a footpad was challenged with epicutaneous PCl. Footpad thickness was measured before and
24 hr after challenge. Five thousand AC-SPL cells were injected into a footpad of mice immunized with TNP-BSA immediately after the footpad was
challenged with epicutaneous PCl. Footpad thickness was measured before and 24 hr after challenge and swelling computed. (A): Effect of
immunizing dose of antigen on DTH-induced swelling in BALB/c (A) C57BL/6 mice (C), Generation of suppressive AC-SPL cells is antigen dose
dependent (B): BALB/c, D: C57BL/6. Data represents the mean swelling +/2 S.E.M. of 12 mice/group , 3 experiments. * p,0.05,NS: not significant.
doi:10.1371/journal.pone.0022496.g004
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the most effective dose of antigen to induce the AC-SPL cells that
suppress the expression of DTH is that which is optimal to induce
DTH [23]. Moreover, the dose of antigen required to induce
DTH or to expand the AC-SPL suppressor cells differs for
BALB/c and C57BL/6 mice. Since the suppression elicited by
the CD8
+ suppressor cells requires interferon-c, (IFN-c [26,27]),
the induction of a Th1 response should foster the activity of these
suppressor T cells. Perhaps the specific increase in CD8
+
suppressor T cell-mediated suppression is due to a conversion
of CD8
+ effector T cells to a suppressive phenotype by TGF-b
[10]. The total number of CD8
+ cells does not increase in the
spleen or lymph nodes after the intracameral injection of antigen
and immunization [4,28]. Overall the proportional increase in
CD8
+ cells is quite small, consistent with an antigen-specific
increase in reactive clones. In other words, observing an increase
in these regulatory cells is observing an antigen-induced increase.
Taken together, the metric generated by the use of limiting
numbers of antigen-specific regulatory T cells provides a method
to quantitatively examine an immune response that generates
these cells
By ‘‘parking’’ splenic CD8
+ suppressor cells in the footpads of
immunized mice we could estimate the stability of the cells or
their function. Three-5 days after injection of these cells into the
footpad there was no suppression of swelling induced by
antigenic challenge. This could be due to the cells emigrating
from the site and/or a loss of function. Since the DTH response
is intact it is likely that the IFN-c required for suppressive
function is present. Presently, we are investigating the basis of
the durability of the splenic regulatory T cells introduced to the
site challenged by antigen. In summary, the expansion of an
antigen-specific CD8
+ regulatory T cell population appears to
b eac o n s e q u e n c eo fa ni m m u n er e s p o n s et ot h ei m m u n o g e n .
The use of the quantitative LTS could provide information on
the parameters required to expand this population as well as
provides a method to quantify antigen-specific, cell-mediated
immunoregulation.
Acknowledgments
We are most appreciative of Anthony Vella, PhD, Department of
Immunology, University of Connecticut Health Center, for his advice
and comments during the investigation and the preparation of the
manuscript.
Author Contributions
Conceived and designed the experiments: RS YL REC. Performed the
experiments: RS YL SP. Analyzed the data: RS YL SP JO REC.
Contributed reagents/materials/analysis tools: REC JO. Wrote the paper:
RS YL REC JO.
Figure 5. Durability of cell-mediated suppression OF DTH-mediated swelling. The footpads of mice immunized with TNP-BSA were
injected with 25000 spleen cells recovered from TNP-BSA-immunized mice that received an intracameral injection of TNP-BSA. The footpads were
challenged with epicutaneous PCl immediately after receiving the spleen cells 0, 3 or 5 days after receiving the spleen cells. Footpad thickness was
measured 24 and 48 hr after challenge with PCl. (A) Percent suppression is calculated as : 100- swelling (mm) immunized mice+regulatory spleen cells.
Swelling (mm) immunized only. Data represents mean suppression +/2 S.E.M. 9 mice/group, 3 experiments. (B) The footpads of mice immunized 11 or
13 days previously with TNP-BSA received id 25000 spleen cells recovered from TNP-BSA-immunized mice that received an intracameral injection of
TNP-BSA and epicutaneous PCl. Swelling was measured 24 and 48 hr after challenge. Data shows the mean swelling (mm) of 8 mice/group, two
experiments. * p,0.01.
doi:10.1371/journal.pone.0022496.g005
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